Ir a inicio

Cómo funciona

Hemos transformado el proceso de búsqueda de clínicas, haciéndolo simple, rápido y personalizado.
Responda algunas preguntasComplete un breve formulario para contarnos sobre su estado de salud y necesidades médicas.
Obtenga ofertas personalizadas3 clínicas seleccionadas especialmente según sus respuestas le proporcionan planes de tratamiento personalizados y presupuestos.
Elija la mejor opciónCompare ofertas y elija la clínica que más le convenga.
También puede consultar las 20 clínicas a continuación.
820К+ pacientes han recibido asistencia desde 2014
50 países
1,500 clínicas
6K+ reseñas
3K+ médicos calificados

¿Cuál es el precio del diagnóstico y los tratamientos de Trombocitopenia en Turquía? Descubra ahora

El costo total del tratamiento de trombocitopenia en Turquía varía según el plan de tratamiento. Un trasplante de médula ósea alogénico de un donante relacionado cuesta 61.000 €. Tanto un trasplante haploidéntico como un trasplante de donante no relacionado, incluida la búsqueda de donantes internacionales, tienen un precio de 89.000 €. Las consultas en línea tienen un precio de 103 €, y los análisis de sangre completos cuestan 4.700 €. El programa de tratamiento se determina después de una evaluación individual de cada paciente por un médico.

EspañaTurquíaMéxico
Tratamiento sintomáticode $800de $300de $150
Plasmaféresisde $1,800de $1,200de $1,100
Intercambio de plasma-de $3,900-
Aféresis terapéutica-de $1,350-
Datos verificados por Bookimed a partir de June 2026, basados en solicitudes de pacientes y cotizaciones oficiales de 65 clínicas en todo el mundo. Los costos medianos se basan en facturas reales (2025–2026) y se actualizan mensualmente. Los precios reales pueden variar.

Descubra las mejores clínicas de tratamiento de Trombocitopenia en Turquía: 20 opciones verificadas y Precios

El ranking de clínicas de Bookimed se basa en algoritmos de data science, ofreciendo una comparación confiable, transparente y objetiva. Tiene en cuenta la demanda de pacientes, las puntuaciones de reseñas (positivas y negativas), la frecuencia de actualización de opciones de tratamiento y precios, la rapidez de respuesta y las certificaciones de las clínicas.
Centro médico Anadolu
Memorial Sisli Hospital
Memorial Bahçelievler Hospital
Memorial Antalya Hospital
Memorial Ataşehir Hospital
4.554 reseñas
Precio a consultar
Más información
Ha visto 5 de 20 clínicas

Obtenga una evaluación médica de tratamiento de Trombocitopenia en Turquía: haga una consulta con 20 médicos experimentados ahora

Ver todos los médicos
verificado

Zafer Gulbas

49 años de experiencia • 3315+ tratamientos realizados

El Prof. Dr. Zafer Gulbas es uno de los mejores hematólogos-oncólogos de Turquía, especializado en trasplantes de médula ósea en el Anadolu Medical Center.

  • Fundador del Centro de Trasplante de Médula Ósea de Anadolu
  • Director de oncología médica desde 2005
  • Formado en centros de prestigio como Fred Hutchinson y MD Anderson
  • Especializado en oncología hematológica
verificado

Ceyhun Bozkurt

36 años de experiencia

El profesor Bozkurt es un destacado hematólogo-oncólogo pediátrico en el Hospital Medical Park Bahcelievler, con formación especializada en las principales instituciones de EE. UU., como el Cincinnati Children's Hospital.

  • Más de 30 años de experiencia en hematología y oncología pediátrica
  • Especialista en trasplante pediátrico de células madre hematopoyéticas
  • Formación en el Dana-Farber Cancer Institute de Harvard en neurooncología
  • Publicación de más de 40 artículos en revistas especializadas sobre trastornos sanguíneos pediátricos
  • Subdirector de la Unidad de Trasplante de Células Madre
verificado

Omur Gokmen Sevindik

12 años de experiencia

El Prof. Sevindik aporta su experiencia de la Clínica Mayo y más de 15 años en hematología, centrándose en trastornos sanguíneos complejos en el Hospital Florence Nightingale de Estambul.

  • Especializarse en hematología con enfoque en la trombocitopenia
  • Publicar 18 artículos en revistas internacionales revisadas por pares
  • Formarse en la Universidad Dokuz Eylül y en la Clínica Mayo
  • Participar en múltiples ensayos clínicos
verificado

Bulent Eser

36 años de experiencia

El profesor Bulent Eser se especializa en hematología con más de 20 años de experiencia, centrándose en la trombocitopenia en el Medical Park Antalya Hospital Complex.

  • Certificación en medicina interna/hematología
  • Miembro del European Group for Blood and Marrow Transplantation
  • Ex miembro de la facultad de la Universidad de Erciyes
  • Investigación publicada en oncología hematológica

Compartir contenido

Historias en video de pacientes de Bookimed

Dayana
Combiné mis vacaciones en Antalya con un chequeo médico.
Procedimiento: Chequeo femenino
Igor
¡Fue genial! Traslados, alojamiento, tratamiento, todo incluido.
Procedimiento: Implante dental
Clínica: WestDent Clinic
Marina
Bookimed se encargó de todo. No tuve que preocuparme por nada.
Procedimiento: Chequeo femenino
Actualizado: 05/27/2022
Escrito por
Olena Sikoza
Olena Sikoza
Сopywriter en español
Copywriter médica certificada responsable del contenido en español de Bookimed. Más de 7 años de experiencia en redacción sobre salud y turismo médico, con formación académica en edición científica y desarrollo de contenidos.
Fahad Mawlood
Editor médico y Científico de datos
Médico general. Ganador de 4 premios científicos. Sirvió en Asia Occidental. Es el ex jefe del equipo médico que soporta a pacientes de habla árabe. Ahora es responsable del procesamiento de datos y la precisión del contenido médico.
Fahad Mawlood Linkedin
Esta página puede incluir información relacionada con diversas afecciones médicas, tratamientos y servicios de salud disponibles en diferentes países. Tenga en cuenta que el contenido se proporciona sólo con fines informativos y no debe interpretarse como asesoramiento médico o orientación. Por favor consulte con su médico o con un profesional médico calificado antes de comenzar o cambiar el tratamiento médico.

Preguntas frecuentes sobre el tratamiento de Trombocitopenia en Turquía

Estas preguntas frecuentes provienen de pacientes reales que buscan atención médica a través de Bookimed. Las respuestas son proporcionadas por coordinadores médicos experimentados y representantes autorizados de las clínicas.

What causes my thrombocytopenia, and is it temporary?

Thrombocytopenia occurs when platelet counts fall below 150,000 per microliter. Viral infections, medications, or pregnancy often cause temporary drops. Chronic cases typically stem from autoimmune disorders like immune thrombocytopenic purpura or bone marrow issues. Diagnosis requires a complete blood count and hematologist consultation.

  • Infection triggers: Viral illnesses like the flu or COVID-19 cause temporary platelet decreases.
  • Medication effects: Certain antibiotics, chemotherapy, or blood thinners can lower counts temporarily.
  • Autoimmune factors: Conditions like immune thrombocytopenic purpura may lead to long-term platelet destruction.
  • Splenic trapping: An enlarged spleen from liver disease can store too many platelets.
  • Diagnostic tools: Specialists use immunograms and blood smears to determine if cases are chronic.

Bookimed Expert Insight: Turkish hematology centers offer high-level expertise for complex blood disorders. Professor Dr. Zafer Gulbas has performed over 3,000 bone marrow transplants. Choosing a center with JCI accreditation ensures standardized safety for diagnostic procedures. Large facilities like Medipol Mega serve over 1,000,000 patients annually. This volume allows doctors to identify rare triggers that smaller clinics might miss.

Patient Consensus: Patients note that a single low reading is not a diagnosis. Tracking recent infections and medications is vital for doctors to find the cause. Those visiting Turkish clinics emphasize getting a thorough workup rather than just a quick fix.

Is my platelet count dangerously low?

A platelet count below 50,000 per microliter is considered severe. Levels under 20,000 are critical and pose a high risk for spontaneous bleeding. Normal ranges fall between 150,000 and 450,000. Turkish hematology centers use immunograms and therapeutic apheresis to stabilize patients with critical thrombocytopenia.

  • Mild range: Counts between 101,000 and 140,000 typically do not pose immediate medical danger.
  • Moderate risk: Levels from 51,000 to 100,000 increase bleeding risks during injuries or surgeries.
  • Severe complications: Below 50,000, patients often experience significant bruising and require immediate clinical precautions.
  • Critical status: Levels under 20,000 require urgent intervention to prevent dangerous internal or spontaneous bleeding.

Bookimed Expert Insight: While numbers matter, Turkish specialists like Prof. Dr. Osman Ilhan focus heavily on apheresis and plasma exchange. Data shows leading clinics manage over 250,000 patients annually. They often prioritize treating the underlying cause, such as ITP or TTP, rather than just the count. Always confirm if your selected clinic has an on-site blood bank for immediate transfusions.

Patient Consensus: Patients note that feeling fine is not proof of safety. Many emphasize checking the surgeon’s specific cutoff and same-day blood test plan before any procedure.

What are the common treatment options in Turkey?

Thrombocytopenia treatment in Turkey centers on symptomatic management and identifying root causes through advanced hematology. JCI-accredited facilities offer diagnostic immunograms and hematologist consultations. Specialists like Dr. Zafer Gulbas utilize established protocols including steroids and intravenous immunoglobulin to stabilize platelet levels and prevent bleeding.

  • Diagnostic precision: Hematologists use immunograms and 256-slice CT scanners to stage conditions.
  • Medical management: Steroids like prednisone serve as standard first-line therapy for immune cases.
  • Emergency stabilization: Facilities provide intravenous immunoglobulin (IVIG) for rapid platelet increases during emergencies.
  • High-volume centers: Medipol Mega University Hospital serves 1,000,000 patients annually with advanced diagnostics.

Bookimed Expert Insight: Turkish hematology centers offer unique depth, with Dr. Zafer Gulbas alone having performed 3,300+ complex procedures. This volume-driven expertise is crucial because platelet disorders often mask underlying conditions. Access to such high-volume specialists at JCI-accredited clinics ensures diagnostic accuracy before starting long-term steroid therapy.

Patient Consensus: Patients emphasize the need for a thorough blood workup to confirm the specific cause of low platelets. They note that private hospitals provide much faster access to labs and imaging than public facilities.

What if the first treatment doesn't work (refractory ITP)?

Refractory ITP occurs when initial steroid treatments fail to maintain safe platelet levels. Turkish hematologists transition to second-line protocols including thrombopoietin receptor agonists, rituximab, or splenectomy. Specialized centers in Istanbul use advanced diagnostics like immunograms to personalize therapy and stabilize platelet counts effectively.

  • Second-line medications: TPO-RAs like eltrombopag stimulate bone marrow to increase platelet production.
  • Advanced apheresis: Techniques like plasmapheresis or therapeutic apheresis help remove harmful antibodies.
  • Surgical intervention: Splenectomy removes the primary site of platelet destruction for long-term remission.
  • Targeted biologics: Rituximab suppresses the immune system cells responsible for destroying platelets.

Bookimed Expert Insight: Data shows that top hematologists like Prof. Osman Ilhan often utilize therapeutic apheresis alongside drug therapy. This combination can be a bridge for patients who do not respond to standard second-line agents. Choosing a center with an on-site blood bank and apheresis unit is vital for refractory cases.

Patient Consensus: Patients note that while steroids often cause a temporary rise and relapse, switching to TPO-agonists frequently provides the first long-term stability. The emotional strain of repeated blood tests is often cited as the most challenging part of the process.

Are there restrictions I must follow during treatment?

Patients treating thrombocytopenia in Turkey must follow strict safety protocols to manage bleeding risks. Primary restrictions include avoiding blood-thinning medications like aspirin and NSAIDs. You must limit high-impact activities to prevent internal bleeding. Specialized hematology centers ensure safety through detailed diagnostic immunograms and hematologist consultations.

  • Medication safety: Avoid aspirin and NSAIDs unless specifically cleared by your hematologist.
  • Physical activity: Skip contact sports and heavy lifting to minimize injury risks.
  • Personal care: Use soft toothbrushes and electric razors to prevent skin cuts.
  • Symptom monitoring: Report any nosebleeds, gum bleeding, or unusual bruising immediately.

Bookimed Expert Insight: Turkish hematology centers like Medipol Mega University Hospital and Anadolu Medical Center leverage high patient volumes to refine safety protocols. Professors like Dr. Zafer Gulbas utilize experience from over 3,000 procedures to tailor individual restriction timelines. This expertise is vital because these centers serve thousands of complex cases annually, ensuring patients receive guidance based on more than just standard theory.

Patient Consensus: Patients emphasize the need to treat any head bump as a medical emergency. They also suggest double-checking every over-the-counter cold medicine with your doctor first.

How can I track my progress if I return home?

Tracking progress after thrombocytopenia treatment in Turkey involves monitoring platelet trends through regular complete blood counts. Patients coordinate with a local hematologist to evaluate follow-up labs. Comparing these results against baseline discharge documents ensures stability. This systematic approach identifies changes in blood cell counts early.

  • Routine monitoring: Schedule repeat complete blood counts with a local hematologist regularly.
  • Symptom logging: Note new bruising, petechiae, or unusual bleeding in a daily journal.
  • Baseline comparison: Compare local lab results against discharge data from Turkish clinics.
  • Expert coordination: Ensure local doctors receive treatment details and target platelet ranges.

Bookimed Expert Insight: Patient data shows that established clinics like Anadolu Medical Center and Hisar Hospital serve over 65,000 to 250,000 patients annually. These high-volume centers often provide detailed discharge summaries based on American treatment standards. A non-obvious tip is to ensure your final Turkish lab report includes your specific platelet baseline. This allows your local doctor to distinguish between a natural fluctuation and a clinical trend.

Patient Consensus: Patients emphasize that a stable count at hospital discharge is only the first step. They recommend tracking energy levels and physical signs like gum bleeding to provide local doctors with concrete data.

Are there English-speaking doctors?

Turkish private hospitals employ many English-speaking hematologists. These specialists often train in the USA, UK, or Japan. Joint Commission International accredited centers provide dedicated international departments. These teams handle coordination and medical translation for patients with thrombocytopenia throughout their stay.

  • Specialist training: Doctors like Dr. Zafer Gulbas and Dr. Ceyhun Bozkurt trained at major American institutions.
  • Advanced credentials: Specialists often hold memberships in the American or European Hematology Associations.
  • Language support: Accredited facilities like Anadolu Medical Center provide specialized interpreters for medical consultations.
  • Resource accessibility: Major Istanbul hospitals provide all medical reports and discharge instructions in English.

Bookimed Expert Insight: While many doctors appear fluent, those at university-affiliated centers often have higher communication standards due to active publishing. Dr. Osman Ilhan has over 300 PubMed publications and 5,000+ citations. This academic focus ensures they are deeply familiar with English medical terminology and international treatment protocols.

Patient Consensus: Patients note that communication quality varies across facilities. They recommend focusing on private hospitals in major cities and suggest sending all medical histories in writing before arrival to ensure clarity.

Pedir una consulta gratis

Seleccione la mejor manera de contactarle